SIGILON THERAPEUTICS
Sigilon Therapeutics is to create immune-protected, engineered human cells that restore normal physiology in a wide range of diseases without generating fibrosis or immune rejection, liberating patients from challenges associated with serious chronic diseases.
SIGILON THERAPEUTICS
Industry:
Biotechnology
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.sigilon.com
Total Employee:
51+
Status:
Active
Contact:
617-336-7540
Email Addresses:
[email protected]
Total Funding:
263.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager WordPress Font Awesome Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
D2G Oncology
D2G Oncology is a biotechnology company that specializes in relating drugs to genotypes to transform precision cancer therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Eli Lilly
Eli Lilly investment in Series B - Sigilon Therapeutics
Longevity Vision Fund
Longevity Vision Fund investment in Series B - Sigilon Therapeutics
BlackRock
BlackRock investment in Series B - Sigilon Therapeutics
Flagship Pioneering
Flagship Pioneering investment in Series B - Sigilon Therapeutics
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board investment in Series B - Sigilon Therapeutics
Eli Lilly
Eli Lilly investment in Series A - Sigilon Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-07-19 | Sigilon Therapeutics Appoints Ajay Rai, M.B.A., as Senior Vice President, Head of Business Development |
Official Site Inspections
http://www.sigilon.com Semrush global rank: 10.15 M Semrush visits lastest month: 39
- Host name: 168.235.117.84
- IP address: 168.235.117.84
- Location: Atlanta United States
- Latitude: 33.8336
- Longitude: -84.3797
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30305
